ATAZANAVIR CIPLA atazanavir 150 mg capsule bottle pack

Maa: Australia

Kieli: englanti

Lähde: Department of Health (Therapeutic Goods Administration)

Aktiivinen ainesosa:

atazanavir sulfate, Quantity: 170.85 mg (Equivalent: atazanavir, Qty 150 mg)

Saatavilla:

Cipla Australia Pty Ltd

INN (Kansainvälinen yleisnimi):

Atazanavir sulfate

Lääkemuoto:

Capsule, hard

Koostumus:

Excipient Ingredients: lactose monohydrate; crospovidone; magnesium stearate; purified water; titanium dioxide; iron oxide red; Gelatin; sodium lauryl sulfate

Antoreitti:

Oral

Kpl paketissa:

60 capsules, 30 capsules

Prescription tyyppi:

(S4) Prescription Only Medicine

Käyttöaiheet:

Atazanavir is indicated for the treatment of HIV 1 infection, in combination with other antiretroviral agents. This indication is based on analyses of plasma HIV-1 RNA levels and CD4 cell counts from controlled studies (See Clinical Trials).

Tuoteyhteenveto:

Visual Identification: White to pale yellow granules filled in size 1 hard gelatin capsule with maroon cap & white body spin printed with Cipla 150 on cap with white ink.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 15 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Valtuutuksen tilan:

Licence status A

Valtuutus päivämäärä:

2017-08-30